Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma

Motaz Qadan, Zhi Ven Fong, Aaron M. Delman, Ahmed Gabr, Riad Salem, Shimul A. Shah*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Background: The incidence of hepatocellular carcinoma (HCC) has been rising, and 80% of HCCs are unresectable at the time of presentation. In recent years, Yttrium-90 (Y90) radioembolization has arisen as a potential tool to treat the primary HCC tumor while also inducing contralateral liver hypertrophy to increase future liver remnant volumes. The goal of this multidisciplinary review is to summarize the contemporary evidence on the safety, efficacy, and utility of Y90 as a bridge to liver resection and transplant in patients with HCC. Methods: A narrative review was conducted of the recent literature regarding the utilization of Y90 as a therapy prior to liver resection or transplant in patients with HCC. A specific emphasis was placed on articles published in the last 10 years. Results: Y90 radioembolization has demonstrated a high safety profile and increasing utility in bridging and downstaging patients with HCC who subsequently undergo liver resection or transplant. The continuous advancements in treatment strategies and radiation dosimetry have paved the way for the incorporation of Y90 in all stages of HCC with different intents, including downstaging and bridging. Conclusions: Y90 radioembolization can be safely used in the HCC population to bridge patients to resection or transplantation, induce future liver remnant growth, and select for less aggressive tumor biology prior to surgery.

Original languageEnglish (US)
Pages (from-to)2690-2699
Number of pages10
JournalJournal of Gastrointestinal Surgery
Issue number10
StatePublished - Oct 2021


  • Hepatocellular carcinoma
  • Liver resection
  • Liver transplant
  • Y90

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology


Dive into the research topics of 'Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Cite this